Nuvigil and Provigil Pregnancy Registry

Study Title
The Nuvigil and Provigil Pregnancy Registry
Teva Identifier
C10953/9022
ClinicalTrials.gov Identifier
NCT01792583
Study Status
Terminated
Trial Condition(s)
Narcolepsy | Obstructive Sleep Apnea | Shift Work Sleep Disorder
Interventions
Drug: Modafinil/armodafinil
Study Description
The primary objective of the Nuvigil/Provigil Pregnancy Registry is to characterize the pregnancy and fetal outcomes associated with Nuvigil and Provigil exposure during
Print

Participation criteria and map of study locations
disease-icon

Key Participation Requirements

Gender
Female
Age Range
Child, Adult, Older Adult
Trial Duration
June 30, 2009 - November 30, 2023

Study Type

Observational